Key result
Each 1% increase in peripheral perfusion index is linked to ~18% fewer major renal events in T2D.
Why the study?
Diabetic kidney disease remains a major cause of end-stage renal disease despite recent therapies, highlighting the need for appropriate markers to predict renal outcomes.
Does peripheral perfusion index predict renal events in patients with type 2 diabetes mellitus?
Cohort (n=566)
No
Does peripheral perfusion index predict renal events in patients with type 2 diabetes mellitus?
Effect estimate: OR 0.823 (95% CI 0.680-0.970)
p-value: p=0.018
Higher peripheral perfusion index is associated with a significantly lower risk of adverse renal events in patients with type 2 diabetes mellitus.
May aid renal risk stratification in type 2 diabetes; leaves open added value and causality pending prospective validation.
Diabetic kidney disease (DKD) is one of the leading causes of end stage renal disease. Despite recent therapies, mortality due to DKD and resources spent on healthcare are important problems. Thus, appropriate markers are needed to predict renal outcomes. Therefore, we investigated the role of peripheral perfusion as an indicator for renal events in patients with type 2 diabetes mellitus. This retrospective cohort study included 566 patients who were admitted to Matsushita Memorial Hospital in Osaka, Japan for type 2 diabetes mellitus. Peripheral perfusion was assessed using perfusion index (PI), which represents the level of circulation through peripheral tissues and was measured on each toe using a Masimo SET Radical-7 (Masimo Corporation, Irvine, CA, USA) instrument. The duration of follow up was 3.0 years. The median age of patients was 70 years (IQR range: 61-77 years) and median PI value was 2.9% (IQR range: 1.8-4.8%). Multiple logistic regression analyses showed that PI (per 1% increase) was associated with an odds ratio of composite of end-stage renal disease (ESRD) and/or doubling of serum creatinine level; n = 40 (odds ratio 0.823 [95% CI: 0.680-0.970]), and composite of ESRD, doubling of serum creatinine level, and renal death and/or cardiovascular death; n = 44 (odds ratio 0.803 [95% CI: 0.665-0.944]). The factors which were statistically significant in univariate analysis and those known to be related factors for renal event were considered simultaneously as independent variables for multiple logistic regression analysis. PI can be a novel indicator for renal events in patients with type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2020) conducted a cohort in Type 2 diabetes mellitus (n=566). Perfusion index (PI) was evaluated on Composite of end-stage renal disease and/or doubling of serum creatinine level (OR 0.823, 95% CI 0.680-0.970, p=0.018). A 1% increase in peripheral perfusion index was associated with a lower risk of the composite of end-stage renal disease and/or doubling of serum creatinine level (OR 0.823) in type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: